Further experience with infection after cardiac transplantation.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004452:Echocardiography; D004562:Electrocardiography; D005260:Female; D006084:Graft Rejection; D016027:Heart Transplantation; D006801:Humans; D007165:Immunosuppression Therapy; D017053:Infection Control; D007239:Infections / Q000209:etiology*; D007538:Isoniazid / Q000627:therapeutic use; D008171:Lung Diseases / Q000175:diagnosis; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009761:Nystatin / Q000627:therapeutic use; D011175:Positive-Pressure Respiration; D013902:Radiography, Thoracic; D012882:Skin Tests; D014374:Tuberculin Test; D014552:Urinary Tract Infections / Q000175:diagnosis; D012122:Ventilators, Mechanical
D000900:Anti-Bacterial Agents; D000961:Antilymphocyte Serum; D009761:Nystatin; D003520:Cyclophosphamide; D001379:Azathioprine; D007538:Isoniazid; D008775:Methylprednisolone